Corteva (NYSE:CTVA) Stock Sees Heavy Call Option Buying

Corteva, Inc. (NYSE:CTVA) saw some unusual options trading activity on Wednesday. Investors bought 5,408 call options on the company. This represents an increase of 532% compared to the typical daily volume of 856 call options.

Key Corteva News

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: JPMorgan upgraded Corteva to Overweight from Neutral and set a $19 price target, implying roughly 34% upside from the cited share price. The firm described the stock as undervalued following the Vylor spinoff. JPMorgan Upgrades Corteva
• Positive Sentiment: KeyBanc also raised Corteva to Overweight, adding to the positive analyst momentum and reinforcing expectations that the post-spinoff company may warrant a higher valuation. KeyBanc Upgrades Corteva
• Positive Sentiment: Bank of America maintained a Buy rating and an $18 target, citing new product launches and expectations for tighter agricultural markets in 2027. The firm believes innovation can offset pressure from older products. Corteva remains a buy
• Positive Sentiment: The series of upgrades prompted reports that Corteva rallied by approximately 9% to 12%, with investors responding to the potential for a simpler business structure, improved focus, and substantial upside to analyst price targets. Corteva Soars on JPMorgan Upgrade
• Neutral Sentiment: Corteva announced that third-quarter 2026 results will be released after the market closes on November 11, followed by a webcast on November 12. The event could provide the next major catalyst and test whether the focused portfolio is improving results. Corteva Third-Quarter Earnings Date
• Negative Sentiment: Some coverage cautions that the recent rally may have moved the shares ahead of fundamentals, raising valuation concerns. Corteva also faces pressure from legacy products and will need successful product launches and stronger agricultural conditions to justify the bullish targets. Could Corteva Turn Its Setup Into Progress

Corteva Price Performance

Shares of NYSE CTVA traded up $0.36 during mid-day trading on Wednesday, reaching $14.27. The company’s stock had a trading volume of 9,930,692 shares, compared to its average volume of 6,182,983. The firm has a market capitalization of $9.52 billion, a PE ratio of 9.44, a P/E/G ratio of 0.38 and a beta of 0.57. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. Corteva has a 52 week low of $11.74 and a 52 week high of $90.97. The stock has a fifty day moving average of $75.82 and a two-hundred day moving average of $79.64.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, beating analysts’ consensus estimates of $2.24 by $0.06. The firm had revenue of $6.38 billion during the quarter, compared to analyst estimates of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The business’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same quarter last year, the business posted $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, sell-side analysts anticipate that Corteva will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st were issued a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 5.0%. The ex-dividend date of this dividend was Tuesday, September 1st. Corteva’s dividend payout ratio (DPR) is currently 47.68%.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. Royal Bank Of Canada reiterated an “outperform” rating and issued a $17.00 price objective on shares of Corteva in a research report on Wednesday. New Street Research set a $17.00 price target on shares of Corteva in a research note on Monday. Barclays boosted their price objective on shares of Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a research note on Thursday, June 11th. Bank of America lifted their price objective on Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a research note on Monday, July 20th. Finally, Argus reaffirmed a “buy” rating and issued a $91.00 price target on shares of Corteva in a research report on Friday, September 18th. Sixteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, Corteva has an average rating of “Moderate Buy” and an average target price of $67.45.

Institutional Investors Weigh In On Corteva

Institutional investors and hedge funds have recently made changes to their positions in the stock. EFG International AG acquired a new position in shares of Corteva in the second quarter valued at about $25,000. Compass Financial Management LLC purchased a new position in Corteva during the second quarter valued at approximately $25,000. Elevation Wealth Partners LLC grew its position in Corteva by 334.6% during the second quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock valued at $29,000 after buying an additional 261 shares during the period. Clearstead Trust LLC purchased a new position in Corteva in the second quarter valued at $31,000. Finally, N.E.W. Advisory Services LLC acquired a new position in shares of Corteva in the second quarter worth about $33,000. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Company Profile

Corteva, Inc is an agriculture-focused company that develops and supplies seed, crop protection and digital agriculture products. Its offerings are designed to help farmers improve crop productivity, manage pests and diseases, and support more efficient and sustainable farming practices.

The company’s seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crops, marketed through brands such as Pioneer, Brevant seeds and PhytoGen. Corteva also provides herbicides, insecticides, fungicides, biological products and seed treatments under a range of agricultural brands.

Corteva serves farmers, agricultural retailers and other customers in markets around the world.